AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 13, 2021

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2026

Conditions
Indeterminate Pulmonary NodulesLung MetastasesSecond Primary CancerLung Cancer
Interventions
OTHER

Non-Interventional Study

First nodule detection CT scans as per eligibility criteria will be used as input into in-house software to extract multiple radiomic features and used to develop a machine learning based classifier to differentiate nodule aetiology. Scans will also be used as input in to a deep learning/convolutional neural network models to perform automated imaging classification.

Trial Locations (2)

SW3 6JJ

RECRUITING

The Royal Marsden NHS Foundation Trust (Chelsea Site), London

SW3 6NP

RECRUITING

Royal Brompton Hospital, London

All Listed Sponsors
collaborator

Institute of Cancer Research, United Kingdom

OTHER

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

collaborator

Royal Marsden Partners Cancer Alliance

UNKNOWN

collaborator

Imperial College London

OTHER

collaborator

Oxford University Hospitals NHS Trust

OTHER

collaborator

National Heart and Lung Institute

OTHER

lead

Royal Marsden NHS Foundation Trust

OTHER